awards grant
- A Non-Inferiority Randomized Controlled Clinical Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Consequent to MST in Male and Female Military Personnel and Veterans
- A Phase II Study of Inhaled CO for the Treatment of ARDS
- A sUPR driver of T cell metabolic dysfunction in ovarian cancer
- A smart soft robotic tool for semi-automated intubation
- ATF4 in ccRCC: A New Therapeutic Approach
- Characterizing 3''-UTR biology as a mechanism of therapy response in high risk prostate cancer.
- Clinical identification and targeting of non-neuroendocrine lineage plasticity in castration-resistant prostate cancer
- Clonal Hematopoiesis as a determinant for bone marrow toxicities for targeted radiation therapies in prostate cancer.
- Converting HR Breast Cancer Into an Individualized Vaccine
- Converting HR+ Breast Cancer Into an Individualized Vaccine
- Defining the impact of Kras mutational heterogeneity on the tumor microenvironment in pancreatic cancer
- Defining the impact of Kras mutational heterogeneity on the tumor microenvironment in pancreatic cancer
- Delineating the role of genetic mutations in Hepatoblastoma development and phenotypes
- Determining Metastatic Drivers of Pten/p53-Loss-Driven Prostate Cancer Using Evolving DNA Barcodes
- Dissecting the role of folate deficiency in lung cancer development and genomic instability
- Elucidating the oncogenic role of EMSY in non-small cell lung cancer
- Enhancing Breast Cancer Therapy by Inhibiting the Adenosine Receptor and Oxygen Consumption
- Extending the survival of HR+ breast cancer patients receiving CDK4/6 inhibitors by targeting IL17-producing gamma delta T cells
- Harnessing Dietary n-3 Fatty Acids to Unleash Protective Immunity Against Ovarian Cancer
- Heating cold prostate tumors with PSMA-targeted alpha therapy and pembrolizumab
- Interplay of DNA methylation and histone methylation driving neuroendocrine phenotype in advanced prostate cancer
- Investigation of UBR5 and its signaling as a novel target for breast cancer therapy
- Mechanism-Based Approach for Combination Therapies with Immune Modulation for Management of Patients with Urothelial Cancers of the Upper Urinary Tract
- Molecular and clinical correlates with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy
- Mutational and Aging Risk Factors for Myelodysplastic Syndrome
- Novel Approach to Improving Prostate Cancer Screening Among African American Men
- Novel Complex Structural Variants And Epigenetic Alterations Link The Genomes Of Prostate Cancer In African Americans With Outcome Disparity.
- PERK-Driven Stress Responses Regulate Dendritic Cell Function in Ovarian Cancer
- Targeted Therapies
- Targeting APOBEC3A-induced chromosomal instability as a driver of metastasis in bladder cancer
- The Annexin A2 Pathway in Proliferative Vitreoretinopathy: A New Therapeutic Target
- The Impact of Military vs. Civilian System Primary Care Providers on Utilization and Care Quality
- The Mechanistic Basis Of Radiation Induced Immunomodulation In Early Non-Small Cell Lung Cancer
- The Role of basic Helix-Loop-Helix (bHLH) Transcription Factors in Glioma-Associated Microglia.
- The Skeletal Stem Cell Basis for Skeletal Fragility
- Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectory
- Ultrasmall PSMA-Targeted Particle Radiotherapy for Regulating the Immunosuppressive Prostate Cancer Tumor Microenvironment and Enhancing Treatment Efficacy